All Stories

  1. Correction to Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer

    Article • Journal of Medicinal Chemistry, February 2020, American Chemical Society (ACS)

    Guy Bormans

  2. Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation

    Article • Diagnostics, January 2020, MDPI AG

    Guy Bormans

  3. Automated GMP compliant production of [18F]AlF-NOTA-octreotide

    Article • EJNMMI Radiopharmacy and Chemistry, January 2020, Springer Science + Business Media

    Guy Bormans, dr Willy Gsell

  4. Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI

    Article • Translational Oncology, January 2020, Elsevier

    Guy Bormans

  5. Binding of [18F]AV1451 in post mortem brain slices of semantic variant primary progressive aphasia patients

    Article • European Journal of Nuclear Medicine and Molecular Imaging, December 2019, Springer Science + Business Media

    Guy Bormans

  6. Development of Superparamagnetic Nanoparticles Coated with Polyacrylic Acid and Aluminum Hydroxide as an Efficient Contrast Agent for Multimodal Imaging

    Article • Nanomaterials, November 2019, MDPI AG

    Guy Bormans, dr Willy Gsell

  7. The Changing Landscape of Early Medicines Development: Be Prepared

    Article • October 2019, Frontiers

    Guy Bormans

  8. Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy

    Article • Experimental Neurology, October 2019, Elsevier

    Guy Bormans

  9. TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study

    Article • Journal of Nuclear Medicine, September 2019, Society of Nuclear Medicine

    Guy Bormans

  10. Design and Challenges of Radiopharmaceuticals

    Article • Seminars in Nuclear Medicine, September 2019, Elsevier

    Guy Bormans

  11. Al18F-NOTA-octreotide: first comparison with 68Ga-DOTATATE in a neuroendocrine tumour patient

    Article • European Journal of Nuclear Medicine and Molecular Imaging, July 2019, Springer Science + Business Media

    Guy Bormans

  12. Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease

    Article • Frontiers in Neuroscience, July 2019, Frontiers

    Guy Bormans

  13. Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma

    Article • Nuclear Medicine and Biology, July 2019, Elsevier

    Guy Bormans

  14. [11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers

    Article • European Journal of Nuclear Medicine and Molecular Imaging, June 2019, Springer Science + Business Media

    Guy Bormans

  15. Preclinical Safety Evaluation and Human Dosimetry of [18F]MK-6240, a Novel PET Tracer for Imaging Neurofibrillary Tangles

    Article • Molecular Imaging and Biology, May 2019, Springer Science + Business Media

    Guy Bormans

  16. Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer

    Article • Journal of Medicinal Chemistry, February 2019, American Chemical Society (ACS)

    Guy Bormans

  17. Preclinical evaluation of [18 F]MA3: a CB2 receptor agonist radiotracer for PET

    Article • British Journal of Pharmacology, January 2019, Wiley

    Guy Bormans

  18. Volume-of-interest-based supervised cluster analysis for pseudo-reference region selection in [18F]DPA-714 PET imaging of the rat brain

    Article • EJNMMI Research, December 2018, Springer Science + Business Media

    Guy Bormans

  19. 18F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446

    Article • Journal of Nuclear Medicine, September 2018, Society of Nuclear Medicine

    Guy Bormans

  20. Direct fluorine-18 labeling of heat-sensitive biomolecules for positron emission tomography imaging using the Al18F-RESCA method

    Article • Nature Protocols, September 2018, Springer Science + Business Media

    Guy Bormans

  21. Single-word comprehension deficits in the nonfluent variant of primary progressive aphasia

    Article • Alzheimer s Research & Therapy, July 2018, Springer Science + Business Media

    Guy Bormans

  22. Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants

    Article • European Journal of Nuclear Medicine and Molecular Imaging, June 2018, Springer Science + Business Media

    Guy Bormans

  23. Brain Imaging of Alzheimer Dementia Patients and Elderly Controls with 18F-MK-6240, a PET Tracer Targeting Neurofibrillary Tangles

    Article • Journal of Nuclear Medicine, June 2018, Society of Nuclear Medicine

    Guy Bormans

  24. Effects of alcohol exposure on the glutamatergic system: a combined longitudinal 18 F-FPEB and 1 H-MRS study in rats

    Article • Addiction Biology, May 2018, Wiley

    Guy Bormans, dr Willy Gsell

  25. Fatty Acid Amide Hydrolase Inhibition by JNJ-42165279: A Multiple-Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers

    Article • Clinical and Translational Science, March 2018, Wiley

    Guy Bormans

  26. Synthesis, Enzyme Assays and Molecular Docking Studies of Fluorina ted Bioisosteres of Santacruzamate A as Potential HDAC Tracers

    Article • Letters in Drug Design & Discovery, June 2017, Bentham Science Publishers

    Guy Bormans